EmphyCorp Patents

Global Drug Patents have been granted in Spain, Austria, UK, Ireland, Italy, Germany, France, Sweden, Canada, Mexico, Australia, New Zealand, China, Philippines, South Africa, Japan, Taiwan, and Brazil.

This does not include New PCT Patents filed or to be filed. All our Patents cover the use of pyruvate to treat lung and sinus diseases with sodium pyruvate or any pyruvate analog including ethyl pyruvate and amino acid pyruvates.

Our recent granted Chinese Patent was granted for the treatment of all lung diseases with any and all Patented or Non-patented Drugs, providing EmphyCorp with a huge range of Patent protected products that can be used in China. 


Our Products

Please see "Our Products" Tab on the Home Page